C. Kemal Buharalıoğlu

670 total citations
30 papers, 580 citations indexed

About

C. Kemal Buharalıoğlu is a scholar working on Physiology, Biochemistry and Immunology. According to data from OpenAlex, C. Kemal Buharalıoğlu has authored 30 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 17 papers in Biochemistry and 9 papers in Immunology. Recurrent topics in C. Kemal Buharalıoğlu's work include Nitric Oxide and Endothelin Effects (17 papers), Eicosanoids and Hypertension Pharmacology (17 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). C. Kemal Buharalıoğlu is often cited by papers focused on Nitric Oxide and Endothelin Effects (17 papers), Eicosanoids and Hypertension Pharmacology (17 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). C. Kemal Buharalıoğlu collaborates with scholars based in Türkiye, United States and Cyprus. C. Kemal Buharalıoğlu's co-authors include Bahar Tunçtan, Kafait U. Malik, Belma Korkmaz, Seyhan Şahan-Fırat, Ayse Nihal Sari, John R. Falck, Chi Young Song, Fatma Akar, Fariborz A. Yaghini and Mehmet Sami Serin and has published in prestigious journals such as The FASEB Journal, Journal of Pharmacology and Experimental Therapeutics and Journal of Ethnopharmacology.

In The Last Decade

C. Kemal Buharalıoğlu

29 papers receiving 560 citations

Peers

C. Kemal Buharalıoğlu
C. Kemal Buharalıoğlu
Citations per year, relative to C. Kemal Buharalıoğlu C. Kemal Buharalıoğlu (= 1×) peers Seyhan Şahan-Fırat

Countries citing papers authored by C. Kemal Buharalıoğlu

Since Specialization
Citations

This map shows the geographic impact of C. Kemal Buharalıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Kemal Buharalıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Kemal Buharalıoğlu more than expected).

Fields of papers citing papers by C. Kemal Buharalıoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Kemal Buharalıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Kemal Buharalıoğlu. The network helps show where C. Kemal Buharalıoğlu may publish in the future.

Co-authorship network of co-authors of C. Kemal Buharalıoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of C. Kemal Buharalıoğlu. A scholar is included among the top collaborators of C. Kemal Buharalıoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Kemal Buharalıoğlu. C. Kemal Buharalıoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aksun, Saliha, et al.. (2025). Trimethylamine N-oxide as a potential prognostic biomarker for mortality in patients with COVID-19 disease. Advances in Medical Sciences. 70(1). 174–183.
2.
Sari, Ayse Nihal, Bahar Tunçtan, Ayşegül Görür, et al.. (2017). Activation of mTOR/IκB-α/NF-κB pathway contributes to LPS-induced hypotension and inflammation in rats. European Journal of Pharmacology. 802. 7–19. 62 indexed citations
4.
Sari, Ayse Nihal, C. Kemal Buharalıoğlu, Belma Korkmaz, et al.. (2013). Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats. European Journal of Pharmacology. 723. 234–245. 20 indexed citations
6.
Şahan-Fırat, Seyhan, Belma Korkmaz, Hatice Kalkan Yı̇ldırım, et al.. (2012). Increased Production of Nitric Oxide Mediates Selective Organ-Specific Effects of Endotoxin on Oxidative Stress. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 11(2). 161–172. 5 indexed citations
7.
Tunçtan, Bahar, Ayse Nihal Sari, C. Kemal Buharalıoğlu, et al.. (2012). NS-398 reverses hypotension in endotoxemic rats: Contribution of eicosanoids, NO, and peroxynitrite. Prostaglandins & Other Lipid Mediators. 104-105. 93–108. 17 indexed citations
8.
Korkmaz, Belma, C. Kemal Buharalıoğlu, Abdullah Tuncay Demiryürek, et al.. (2012). Contribution of MEK1/ERK1/2/iNOS Pathway to Oxidative Stress and Decreased Caspase-3 Activity in Endotoxemic Rats. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 11(3). 243–252. 4 indexed citations
9.
Tunçtan, Bahar, Belma Korkmaz, Ayse Nihal Sari, et al.. (2012). A Novel Treatment Strategy for Sepsis and Septic Shock Based on the Interactions between Prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic Acid. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 11(2). 121–150. 28 indexed citations
10.
Korkmaz, Belma, C. Kemal Buharalıoğlu, Seyhan Şahan-Fırat, et al.. (2010). A Synthetic Analogue of 20‐HETE, 5,14‐HEDGE, Reverses Endotoxin‐Induced Hypotension via Increased 20‐HETE Levels Associated with Decreased iNOS Protein Expression and Vasodilator Prostanoid Production in Rats. Basic & Clinical Pharmacology & Toxicology. 106(5). 378–388. 23 indexed citations
11.
Tunçtan, Bahar, Belma Korkmaz, C. Kemal Buharalıoğlu, et al.. (2010). Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase‐2 Inhibitor, NS‐398, on Endotoxin‐Induced Hypotension in Rats. Basic & Clinical Pharmacology & Toxicology. 107(5). 877–882. 21 indexed citations
13.
Tunçtan, Bahar, Belma Korkmaz, C. Kemal Buharalıoğlu, et al.. (2008). A 20-HYDROXYEICOSATETRAENOIC ACID AGONIST, N-[20-HYDROXYEICOSA-5(Z),14(Z)-DIENOYL]GLYCINE, OPPOSES THE FALL IN BLOOD PRESSURE AND VASCULAR REACTIVITY IN ENDOTOXIN-TREATED RATS. Shock. 30(3). 329–335. 29 indexed citations
14.
Buharalıoğlu, C. Kemal, et al.. (2007). The Effects of Bumetanide on Human Umbilical Artery Contractions. Reproductive Sciences. 14(3). 246–252. 3 indexed citations
16.
Tunçtan, Bahar, Belma Korkmaz, Hatice Kalkan Yı̇ldırım, et al.. (2006). Reversal of endotoxin-induced hypotension by inhibition of inducible nitric oxide synthase activity is associated with improved oxidative status in rat heart, aorta and mesenteric artery. TURKISH JOURNAL OF MEDICAL SCIENCES. 36(2). 71–80. 9 indexed citations
17.
Korkmaz, Belma, et al.. (2006). Involvement of calcium/calmodulin-dependent protein kinase II to endotoxin-induced vascular hyporeactivity in rat superior mesenteric artery. Pharmacological Research. 54(3). 208–218. 7 indexed citations
18.
Tunçtan, Bahar, et al.. (2005). Nitric oxide reverses endotoxin-induced inflammatory hyperalgesia via inhibition of prostacyclin production in mice. Pharmacological Research. 53(2). 177–192. 24 indexed citations
19.
Buharalıoğlu, C. Kemal & Fatma Akar. (2002). The reactivity of serotonin, acetylcholine and kcl-induced contractions to relaxant agents in the rat gastric fundus. Pharmacological Research. 45(4). 325–331. 15 indexed citations
20.
Çalış, İhsan, et al.. (2000). Studies on the vascular effects of the fractions and phenolic compounds isolated from Viscum album ssp. album. Journal of Ethnopharmacology. 72(1-2). 323–329. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026